Cytokeratin 5/6 Phenotypic Expression in Urothelial Bladder Carcinoma: Relation to Clinicopathological Parameters, FAP and CD147 Immunohistochemical Expression - Egyptian Knowledge Bank - troweb

163848

Cytokeratin 5/6 Phenotypic Expression in Urothelial Bladder Carcinoma: Relation to Clinicopathological Parameters, FAP and CD147 Immunohistochemical Expression

Article

Last updated: 04 Jan 2025

Overview Similar Items

Article

Impact of SOX2 and CD44 as Cancer Stem Cell Markers in Urinary Bladder Carcinoma

Article

Role of Trop2, Cyclin D1 and FOXP3 in bladder carcinoma in Egyptian patients: An immunohistochemical study

Article

Role of YAP1 and Tumor Associated Macrophages (TAMs) in Urothelial Carcinoma of Urinary Bladder: Histopathological and Immunohistochemical Study

Article

Keratin 17 Immunohisto chemical Expression and Prognostic Value in Bladder Urothelial Carcinoma

Article

Assessment of PD-L1 and p53 expression in urinary bladder carcinoma: Association with different clinicopathologic characteristics

Article

The role of Her 2 neu and N-cadherin expression in hepatocellular carcinoma

Article

Role of HER2 and Claudins in Subtypes of Urothelial Carcinoma Identified Bygata3 and Cytokeratin5\6 Immunohistochemical Study

Article

GATA3 and CK5/6 Immunohistochemical Expression in Urothelial Carcinoma: Diagnostic, Biological and Prognostic Significance

Article

c-erbB-2 EXPRESSION IN INVASIVE TRANSITIONAL AND SQUAMOUS CELL CARCINOMA OF THE SCHISTOSOMAL URINARY BLADDER:AN IMMUNOHISTOCHEMICAL AND CLINICAL STUDY

Article

EXPRESSION OF CYTOKERATIN 7, 20, 14 IN UROTHELIAL CARCINOMA AND SQUAMOUS CELL CARCINOMA OF THE EGYPRIAN URINARY BLADDER CANCER